Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
02/02/1999 | US5866124 Antiidiotypic antibodies for high molecular weight-melanoma associated antigen |
02/02/1999 | US5866123 Gene encoding cationic amino acid transporter protein |
02/02/1999 | US5866117 Genetic engineering |
02/02/1999 | CA2169987C Gel form of a vaccine |
02/02/1999 | CA1340373C Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin |
02/02/1999 | CA1340372C Production of e. coli lt-b enterotoxin subunit |
02/01/1999 | CA2238672A1 Seca |
02/01/1999 | CA2238670A1 A novel smad3 splice variant as a target in chronic renal failure, atherosclerosis and fibrosis |
01/29/1999 | CA2239266A1 Novel histidine kinase |
01/28/1999 | WO1999004265A2 Cancer associated nucleic acids and polypeptides |
01/28/1999 | WO1999004237A2 Diagnosis of spongiform encephalopathies using prionins |
01/28/1999 | WO1999004040A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
01/28/1999 | WO1999004029A2 A swine hepatitis e virus and uses thereof |
01/28/1999 | WO1999004018A1 Chimeric contraceptive vaccines |
01/28/1999 | WO1999004011A2 Hiv-1 group o antigens and uses thereof |
01/28/1999 | WO1999004010A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus |
01/28/1999 | WO1999004009A1 Method of dna vaccination using dna encoding antigen and encoding il6 |
01/28/1999 | WO1999004008A2 Cloned genomes of infectious hepatitis c viruses and uses thereof |
01/28/1999 | WO1999003992A1 Trail receptor |
01/28/1999 | WO1999003989A1 Human atp-binding cassette transport protein |
01/28/1999 | WO1999003987A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
01/28/1999 | WO1999003972A1 Cytotoxic t lymphocytes |
01/28/1999 | WO1999003885A1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
01/28/1999 | WO1999003875A1 Nucleotide sequence of the nucleocapsid gene of oropouche virus |
01/28/1999 | WO1999003871A1 Hexadecasaccharide-protein conjugate vaccine for shigella dysenteriae type 1 |
01/28/1999 | WO1999003502A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
01/28/1999 | WO1999003501A1 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide |
01/28/1999 | WO1999003500A1 Improved vaccines and method therefor |
01/28/1999 | WO1999003499A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
01/28/1999 | WO1999003490A1 Proteins and peptides for contraceptive vaccines and fertility diagnosis |
01/28/1999 | WO1998049333A3 Eukaryotic gene expression cassette and uses thereof |
01/28/1999 | WO1998049303A3 Compositions and methods for conferring tick immunity and preventing tick borne diseases |
01/28/1999 | WO1998048000A3 A cell strain with activated anti-cancer cytotoxic activity |
01/28/1999 | WO1998047530A3 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |
01/28/1999 | CA2297072A1 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide |
01/28/1999 | CA2296736A1 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
01/28/1999 | CA2296447A1 Human atp-binding cassette transport protein |
01/28/1999 | CA2296442A1 Hiv-1 group o antigens and uses thereof |
01/28/1999 | CA2296089A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus |
01/28/1999 | CA2295926A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
01/28/1999 | CA2295719A1 Trail receptor |
01/28/1999 | CA2295552A1 Cloned genomes of infectious hepatitis c viruses and uses thereof |
01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
01/27/1999 | EP0893507A1 Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment |
01/27/1999 | EP0893505A2 Novel glucose kinase |
01/27/1999 | EP0893504A1 Polypeptide coded by the Kaposi sarcoma-associated virus (KSHV, HHV-8) and its uses in diagnostic and therapy |
01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
01/27/1999 | EP0893502A2 GreA from Staphylococcus aureus |
01/27/1999 | EP0893501A2 Ferrichrome transport atp-binding protein |
01/27/1999 | EP0893500A2 BmrU gene from Staphylococcus aureus |
01/27/1999 | EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus |
01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
01/27/1999 | EP0893496A2 Histidyl tRNA synthetase from Chlamydia trachomatis |
01/27/1999 | EP0893495A2 Isoleucyl tRNA synthetase from Chlamydia trachomatis |
01/27/1999 | EP0893494A2 Aspartyl tRNA synthetase from Chlamydia trachomatis |
01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
01/27/1999 | EP0893450A1 Chromatographic method for high yield purification and viral inactivation of antibodies |
01/27/1999 | EP0893124A1 Pharmaceutical combination preparations comprising human monoclonal antibodies for the treatment of chronic hepatitis B and a virostatic substance |
01/27/1999 | EP0892643A1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
01/27/1999 | EP0892640A2 Enteric-coated pharmaceutical compositions of mycophenolate |
01/27/1999 | EP0542770B1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
01/27/1999 | EP0461177B1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine |
01/27/1999 | CN1206350A Hybrid with interferon-'alpha' and immunoglobulin Fc linkes through non-immunogenic peptide |
01/27/1999 | CN1205897A Deativation vaccine for cholera fowl emulsion and its preparation |
01/26/1999 | US5864027 HIV envelope polypeptides |
01/26/1999 | US5864019 Antigen-binding protein comprising: 3 or 4 vh domains; spacing polypeptide attached to c-terminal end of each vh domain; linkage polypeptide containing linkable residues attached to c-terminal end of each spacing polypeptide; vl domain |
01/26/1999 | US5864008 Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides |
01/26/1999 | US5863944 Compounds and compositions for delivering active agents |
01/26/1999 | US5863890 Smooth muscle relaxants; anticoagulants; vasodilation; protein regulation; cellular metabolism; blood oxygen transport |
01/26/1999 | US5863804 Monoclonal or polyclonal antibodies obtained by administering to an animal a synthetic peptide or a recombinant protein fragment having a partial sequence of t-cadherin, isolating from animal's serum |
01/26/1999 | US5863796 Immunizing a mammal with specific polypeptide and collecting the antibody |
01/26/1999 | US5863787 Kaposi's sarcoma-associated herpesvirus (KSHV) glycoprotein B (GB) and uses thereof |
01/26/1999 | US5863780 A polynucleotide sequence encodes human protein kinase polypeptide; culture product |
01/26/1999 | US5863779 UBC7-like ubiquitin-conjugating enzyme |
01/26/1999 | US5863777 DNA encoding alanyl tRNA synthetase from streptococcus pneumonine |
01/26/1999 | US5863769 DNA encoding interleukin-1 receptor antagonist (IL-1raβ) |
01/26/1999 | US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders. |
01/26/1999 | US5863757 An expression vector comprising polynucleotide having an open reading frame operably linked to a promoter and encoding a specific polypeptide |
01/26/1999 | US5863755 Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-κ |
01/26/1999 | US5863745 Contacting cells targeted to be killed with a cytotoxic amount of an antibody-pe40 recombinant fusion protein, wherein said antibody is a single-chain fv fragment (scfv) and said pe40 is a pseudomonas exotoxin fragment |
01/26/1999 | US5863739 Assay and kit for the detection of α platelet derived growth factor receptor |
01/26/1999 | US5863735 Human transmembrane 4 superfamily protein |
01/26/1999 | US5863718 Small peptides which inhibit to T-4 receptors and act as immunogens |
01/26/1999 | US5863543 Camp factor of streptococcus uberis |
01/26/1999 | US5863542 Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts |
01/26/1999 | US5863541 Proteins in cells |
01/26/1999 | US5863537 Polypeptide comprising a variable region having the amino acid sequence of the variable region selected from the group consisting of h25d2h-1, h25d2h-2, h25d2h-3, h25d2h-4 and h25d2h-5 |
01/26/1999 | US5863528 Porcine cytokines |
01/26/1999 | US5863517 Process for the preparation of an organ-specific substance labeled with technetium-99m |
01/26/1999 | CA2137639C Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivate thereof having anti-tumor activity and use thereof in the therapy of malignant diseases |
01/26/1999 | CA2005291C Feline infectious peritonitis virus diagnostic tools |
01/26/1999 | CA1340353C Compositions and methods for removal of detergents |
01/26/1999 | CA1340350C Monoclonal antibody to the 75 kd subunit of the human interleukin-2 receptor and use thereof |
01/25/1999 | CA2238664A1 Novel regulator |
01/25/1999 | CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor |
01/24/1999 | CA2238658A1 Novel grea |
01/23/1999 | CA2238682A1 Novel asps |
01/23/1999 | CA2238679A1 Novel phes |
01/23/1999 | CA2238677A1 Novel iles |
01/23/1999 | CA2238674A1 Novel tetracycline resistance protein |